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Abstract
Objective: Resistance to quinolones in E. coli clinical isolates has become an emerging challenge,
especially in hospitalized patient and health care settings, since the introduction of quinolones for 
the treatment soma of infections. Plasmid mediated quinolone resistance (PMQR) plays an 
important role in the development of clinical resistance to quinolone. The aim of this study was to 
investigate PMQR determinants among extended- -lactamases (ESBL)-producing E. 
coli recovered from patients with nosocomial urinary tract infection (UTI). Methods: In our study, 
150 ESBL-producing E. coli collected from 380 patients who met the UTI criteria. Phenotypic 
identification for ESBL production was confirmed by double disc synergy test and Combined Disc 
Diffusion test. In vitro susceptibility of ESBL isolates to 15 antimicrobial agents was performed 
by Kirby- (KBDD) method according to Clinical and Laboratory Standards 
Institute (CLSI, 2012) guidelines. The prevalence of PMQR determinants among ESBL-producing 
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E. coli were assessed using PCR method. Results: The prevalence of ESBL positive E. coli 
isolates in nosocomial UTIs was 55.6%. In antibiotic susceptibility test of ESBL-producing E. 
coli showed that all isolates were resistant to amoxicillin and penicillin and resistance rates to the 
other of antibiotics varied between 96% and 40%. As expected, the majority of isolates were 
highly susceptible to amikacin 72.7% and imipenem 88%. The most predominant PMQR 
genotype was aac(6´)-Ib (74.7%). Among 150 ESBL E. coli isolates, 10 isolates (6.7%) were 
positive for the qnr gene, including 5 for qnrA, 3 for qnrS and 2 for qnrB. Both oqxA and oqxB 
were detected in our isolates but their prevalence was low. Coexistence of ESBL and PMQR 
genes was identified in 107 (71.3%) E. coli isolatesٍ Conclusion: The data of our study 
highlighted that the dissemination PMQR determinants among ESBL-producing E. coli recovered 
from patients with nosocomial UTI is relatively high. Continuous surveillance and introduction 
of guidelines for use of appropriate antibiotic should be seriously considered in Iran.
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